her2-low as a separate entity for defining her2 bc and its prognostic and biological significance
Published 1 year ago • 49 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
0:46
biological behaviour of her2-low bc is dependent on hr expression
-
1:36
is her2-low a distinct subtype of breast cancer?
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
6:51
adcs for her2 and her2-low breast cancer
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
13:08
her2 positive breast cancer: everything you must know
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
11:25
podcast 293: her2-“low” breast cancer and its reponse to an antibody-drug conjugate
-
1:08
findings indicate her2-low and her2-negative breast cancer are biology indistinct
-
1:09
the exciting new field of her2-low breast cancer
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
1:33
questions remaining in the field of her2-low breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
19:47
unfold her2 spectrum from her2 to her2 low mbc between now, past and future
-
13:09
get all the info you need about her2 ve breast cancer - her2 ve breast cancer || dr liz o'riordan